Robert has extensive experience in the medical device, biotech and pharmaceutical industries.
He oversaw the development and launch of over 10 different products while at Boston Scientific and Medtronic.
As a Global Project Manager for Genentech, he focused on biologics for the treatment of HER2+ breast cancer, including Perjeta, Herceptin and Kadcyla.
Robert holds a graduate degree in Industrial Engineering from the University of Costa Rica and an MBA from Harvard Business School.
